Pace Logo

Life Sciences

Pace Life Sciences San German Laboratory

Pace® Life Sciences Announces Successful Outcomes Following US FDA Inspection of Operations in San German, Puerto Rico

Uncategorized /

Long-standing reputation for robust quality is confirmed as company enters 2024  SAN GERMAN, PR., March 28, 2024 (NEWSWIRE.COM): Pace® Life Sciences, LLC, a full-service FDA-registered central laboratory and contract development and manufacturing organization (CDMO) announced the receipt of an overall positive review from The Food & Drug Administration (FDA), following a three-day general inspection of […]

Pace® Life Sciences Announces Successful Outcomes Following US FDA Inspection of Operations in San German, Puerto Rico Read More »

Pace Life Sciences Scientist Working in Laboratory

Pace® Life Sciences Acquires New Jersey Laboratory from Curia

Uncategorized /

Former Whitehouse Analytical Laboratory is Now Part of the Pace® Laboratory Network Minneapolis, MN [March 14, 2024] Pace® Life Sciences, LLC, a contract development, and manufacturing organization (CDMO), announced today that it has acquired the Lebanon, New Jersey laboratory facility (formerly Whitehouse Analytical Laboratories) from Curia, a global contract research, development, and manufacturing (CDMO) company.

Pace® Life Sciences Acquires New Jersey Laboratory from Curia Read More »

Dawn Von Rohr, Pace Life Sciences

Pace® Life Sciences Appoints Dawn Von Rohr as Division President

Uncategorized /

Pace® Life Sciences Appoints Dawn Von Rohr as Division President Von Rohr brings over 25 years of experience to company  Pace® Life Sciences, a full-service contract development and manufacturing organization (CDMO) and a Division of Pace®, a Science and Technology Company, announced today that Dawn Von Rohr has been named Division President. Von Rohr will be

Pace® Life Sciences Appoints Dawn Von Rohr as Division President Read More »

Crucial Role of Testing Labs in Pipeline Emergency Response

Uncategorized /

By John Gerken, Vice President of Corporate Accounts and Specialty Analytical Services, Pace  (P&GJ) — Emergency situations, like explosions due to pipeline ruptures, often happen instantly and without warning. Pipeline managers know about the risks that come with the job, but the aftereffects of pipeline ruptures and leaks are often secondary to protecting human life. 

Crucial Role of Testing Labs in Pipeline Emergency Response Read More »

Capsule Equipment, Pace Life Sciences

Pace® Life Sciences Adds Liquid Capsule Filling Technology

Uncategorized /

Pace® Life Sciences continues to make investments to broaden their comprehensive suite of oral solid dose development offerings. ANN ARBOR, Mich., December 19, 2023 (Newswire) – Pace® Life Sciences, a full-service contract development and manufacturing organization (CDMO) and a Division of Pace®, a Science and Technology Company, adds liquid capsule filling technology to their comprehensive suite of

Pace® Life Sciences Adds Liquid Capsule Filling Technology Read More »

Delnova Unveils Partnership With Pace® Life Sciences To Boost Capabilities

Uncategorized /

DelNova’s partnership will enable clinical development of its lead candidate ReViVox® for the rescue of undesirable outcomes which may arise from a botulinum neurotoxin (BoNT) treatment such as Botox®. Pace® Life Sciences provides a full suite of contract CMC development, clinical trials materials manufacturing, and regulatory compliance, services to the biopharmaceutical industries. SAN DIEGO, Oct.

Delnova Unveils Partnership With Pace® Life Sciences To Boost Capabilities Read More »

Interview with Greg Kupp – President Life Sciences Division & Frank Tagliaferri – VP of Technical Development Pace® Life Sciences

Uncategorized /

Greg Kupp – President Life Sciences Division & Frank Tagliaferri – VP of Technical DevelopmentPace® Life Sciences were recently interviewed by Investment Reports. Read the full inter view here.

Interview with Greg Kupp – President Life Sciences Division & Frank Tagliaferri – VP of Technical Development Pace® Life Sciences Read More »

ReveraGen Completes NDA Submission to FDA for Vamorolone in Duchenne Muscular Dystrophy

Uncategorized /

Pace ® is happy to share news from our client, ReveraGen BioPharma Inc., on a significant accomplishment! ReveraGen Completes NDA Submission to FDA for Vamorolone in Duchenne Muscular Dystrophy. Pace® Ann Arbor (legacy Velesco Pharmaceutical Services) contributed significantly to this success. Velesco Pharma (now Pace®) performed the drug product clinical formulation development and all drug

ReveraGen Completes NDA Submission to FDA for Vamorolone in Duchenne Muscular Dystrophy Read More »

Pace® Life Sciences Acquires Biopharma Global, Expanding FDA Regulatory Affairs Strategy and Consulting Capabilities to the Biotechnology and Pharmaceutical Markets

Uncategorized /

Acquisition allows Pace® to provide full-service regulatory strategy and consulting services to advance FDA submissions across a wide range of therapeutic classes. Minneapolis, MN, September 1, 2022 – Pace® Life Sciences, LLC, a full-service contract development and manufacturing organization (CDMO) and subsidiary of Pace®, ascience and technology company, announced today that it has acquired Biopharma

Pace® Life Sciences Acquires Biopharma Global, Expanding FDA Regulatory Affairs Strategy and Consulting Capabilities to the Biotechnology and Pharmaceutical Markets Read More »